Skip to main content
. 2017 Sep 15;8(60):101130–101145. doi: 10.18632/oncotarget.20926

Table 1. Association between clinicopathological characteristics and KHSRP expression.

Clinicopathological factors n KHSRP immunoreactivity (Cytoplasm) P valuea KHSRP immunoreactivity (Nucleus) P valuea
High (%) Low (%) High (%) Low (%)
Total 104 59 (56.7) 45 (43.3) 68 (65.4) 36 (34.6)
Gender
Male 85 46 (54.1) 39 (45.9) 0.3116 54 (63.5) 31 (36.5) 0.5944
Female 19 13 (68.4) 6 (31.6) 14 (73.7) 5 (26.3)
Age
Mean ± SD (yr) 64.1 ± 8.4 63.2 ± 7.6 65.3 ± 9.3 0.2031 64.1 ± 8.1 64.1 ± 9.1 0.9758
Histopathological grading
Well and moderately differentiated 75 43 (57.3) 32 (42.7) 1.0000 44 (58.7) 31 (41.3) 0.0227
Poorly differentiated 29 16 (55.2) 13 (44.8) 24 (82.8) 5 (17.2)
Lymphatic invasion (ly)
Negative 45 23 (51.1) 22 (48.9) 0.3263 31 (68.9) 14 (31.1) 0.5397
Positive 59 36 (61.0) 23 (39.0) 37 (62.7) 22 (37.3)
Venous invasion (v)
Negative 73 37 (50.7) 36 (49.3) 0.0828 44 (60.3) 29 (39.7) 0.1166
Positive 31 22 (71.0) 9 (29.0) 24 (77.4) 7 (22.6)
Depth of tumor invasion (pT)
pT1 56 27 (48.2) 29 (51.8) 0.0747 32 (57.1) 24 (42.9) 0.0654
pT2-4 48 32 (66.7) 16 (33.3) 36 (75.0) 12 (25.0)
N stage (pN)
pN0 55 32 (58.2) 23 (41.8) 0.8435 35 (63.6) 20 (36.4) 0.8367
pN1-3 49 27 (55.1) 22 (44.9) 33 (67.3) 16 (32.7)
pStage
pI 43 23 (53.5) 20 (46.5) 0.6882 24 (55.8) 19 (44.2) 0.0976
pII-VI 61 36 (59.0) 25 (41.0) 44 (72.1) 17 (27.9)

Statistically significant values are in boldface type.

aP values are from χ2 or Fisher's exact test and were statistically significant at < 0.05.